PharmiWeb.com - Global Pharma News & Resources

Press Releases

Date Title Company
15-Oct-2024 Applied DNA to Participate in the 2024 Maxim Healthcare Virtual Summit on Wednesday, October 16 AccessWire
15-Oct-2024 Dysmenorrhea Treatment Market Expected to Reach USD 13,906.5 Million by 2033 at a 8.3% of CAGR MARKITWIRED
15-Oct-2024 Hypha Laboratories Establishes Scientific and Cultural Advisory Board, Adds William Padilla-Brown AccessWire
15-Oct-2024 1upHealth Launches 1up Patient Connect Product Update to Enhance Patient Data Interoperability Across the Industry AccessWire
15-Oct-2024 Lynred concludes biggest space contract: Meteosat Third Generation Mission led by European Space Agency Andrew Lloyd Associates
15-Oct-2024 Dr. Amir Bajoghli and Skin & Laser Dermatology Center Introduce Venus Viva for Advanced Acne Scar Treatment AccessWire
15-Oct-2024 Minnesota-Based Saint Therese to Acquire St. Mary of the Woods Senior Community in Avon, Ohio AccessWire
15-Oct-2024 OptiMed Health Partners Named 2023 Pioneer in URAC’s Leaders in Performance Measurement Recognition Program AccessWire
15-Oct-2024 Quality & Client Satisfaction Help Lash Me NYC Remain the #1 Lash Salon in Carroll Gardens and Brooklyn Heights AccessWire
15-Oct-2024 Ripple Therapeutics Announces Evaluation and Licensing Agreements with Glaukos AccessWire
15-Oct-2024 Xcelerate, Inc. Issues Shareholder Update AccessWire
15-Oct-2024 Lexaria Announces $5 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules AccessWire
15-Oct-2024 Seraxis Announces FDA IND Allowance for Clinical Study of SR-02 Replacement Islets for Type 1 Diabetes Newswire
15-Oct-2024 CBD Life Sciences, Inc. (CBDL) Announces Strategic MOU With U.S. Armed Forces for Groundbreaking Mushroom Supplement AccessWire
15-Oct-2024 Revival Health Inc. Partners With BSS Health to Bring Affordable GLP-1 Obesity Medication to Mississippians Following Policy Change at Mississippi Board of Medical Licensure AccessWire
15-Oct-2024 Seraxis Announces FDA IND Allowance for Clinical Study of SR-02 Replacement Islets for Type 1 Diabetes AccessWire
15-Oct-2024 Perceiv AI Welcomes Simona Skerjanec to Board of Directors Newswire
15-Oct-2024 NLS Pharmaceutics Ltd. Announces Closing of Private Placement and Expected Compliance with Nasdaq Continued Listing Rules AccessWire
15-Oct-2024 Perceiv AI Welcomes Simona Skerjanec to Board of Directors AccessWire
15-Oct-2024 GB Sciences Signs Licensing Deal With EndoPure Life Sciences for 5% Gross Sales Royalty & Sponsorship of First-in-Human Trial for Their Cannabinoid-Based Parkinson’s Drug AccessWire